Brews You Can Use
Well, this is disappointing. I bought a chunk of this stock last summer: Fevertree Erases Year's Gains as Analyst Warns of 'Gin Fatigue'. Then again, I bet on Fever Tree because I thought the U.S. market was still relatively untapped, and I might be right about that:
While Fevertree has “good momentum” in the U.S., gains are normalizing in the U.K. and there are signs of “moderating gin growth” in markets such as Spain and Belgium.